Predictors of achieving and sustaining glycaemic control and weight loss with tirzepatide in individuals with type 2 diabetes and increased cardiovascular risk (SURPASS-4)

被引：0
|
作者：
Kahn, S. E. [1 ,2 ]
Del Prato, S. [3 ]
Pavo, I. [4 ]
Franco, D. R. [5 ]
Zheng, J. [4 ]
Nicolay, C. [4 ]
Hemmingway, A. [4 ]
Wiese, R. J. [4 ]
Pearson, E. R. [6 ]
机构：
[1] VA Puget Sound Hlth Care Syst, Seattle, WA USA
[2] Univ Washington, Seattle, WA USA
[3] St Anna Sch Adv Studies, Pisa, Italy
[4] Eli Lilly & Co, Indianapolis, IN USA
[5] CPCLIN DASA Clin Res Ctr, Sao Paulo, Brazil
[6] Univ Dundee, Dundee, Scotland
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
757
引用
收藏
页码：S362 / S362
页数：1
相关论文
共 50 条
  • [31] Increased Serum Calcium Levels and Risk of Type 2 Diabetes in Individuals at High Cardiovascular Risk
    Becerra-Tomas, Nerea
    Estruch, Ramon
    Bullo, Monica
    Casas, Rosa
    Diaz-Lopez, Andres
    Basora, Josep
    Fito, Montserrat
    Serra-Majem, Lluis
    Salas-Salvado, Jordi
    DIABETES CARE, 2014, 37 (11) : 3084 - 3091
  • [32] Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum
    Karasik, A
    ANNALS OF MEDICINE, 2005, 37 (04) : 250 - 258
  • [33] Glycaemic control and cardiovascular risk factors in type 2 diabetes: a population-based study
    Bruno, G
    Cavallo-Perin, P
    Bargero, G
    Borra, M
    D'Errico, N
    Pagano, G
    DIABETIC MEDICINE, 1998, 15 (04) : 304 - 307
  • [34] The effect of breakfast skipping and sleep disorders on glycemic control, cardiovascular risk, and weight loss in type 2 diabetes
    Minari, Tatiana Palotta
    Manzano, Carolina Freitas
    Yugar, Louise Buonalumi Tacito
    Sedenho-Prado, Luis Gustavo
    Rubio, Tatiane de Azevedo
    Tacito, Lucia Helena Bonalumi
    Pires, Antonio Carlos
    Vilela-Martin, Jose Fernando
    Cosenso-Martin, Luciana Neves
    Ludovico, Nelson Dinamarco
    Fattori, Andre
    Yugar-Toledo, Juan Carlos
    Moreno, Heitor
    Pisani, Luciana Pellegrini
    CLINICAL NUTRITION ESPEN, 2025, 65 : 172 - 181
  • [35] Effect of improved fitness beyond weight loss on cardiovascular risk factors in individuals with type 2 diabetes in the Look AHEAD study
    Gibbs, Bethany Barone
    Brancati, Frederick L.
    Chen, Haiying
    Coday, Mace
    Jakicic, John M.
    Lewis, Cora E.
    Stewart, Kerry J.
    Clark, Jeanne M.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (05) : 608 - 617
  • [36] Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
    Heerspink, Hiddo J. L.
    Sattar, Naveed
    Pavo, Imre
    Haupt, Axel
    Duffin, Kevin L.
    Yang, Zhengyu
    Wiese, Russell J.
    Tuttle, Katherine R.
    Cherney, David Z. I.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (11): : 774 - 785
  • [37] Improvement of metabolite risk profile for type 2 diabetes and cardiovascular disease by weight loss and weight maintenance
    Danielsson, A. P. H.
    Magnusson, M.
    Geidenstam, N.
    Reinius, L. E.
    Mulder, H.
    Melander, O.
    Ridderstrale, M.
    DIABETOLOGIA, 2013, 56 : S256 - S257
  • [38] Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitus
    Tsukamoto, Shunichiro
    Tanaka, Shohei
    Yamada, Takayuki
    Uneda, Kazushi
    Azushima, Kengo
    Kinguchi, Sho
    Wakui, Hiromichi
    Tamura, Kouichi
    DIABETES OBESITY & METABOLISM, 2024, 26 (01): : 262 - 274
  • [39] Effects of Weight Loss and Interaction with Physical Activity on Risks of Cardiovascular Outcomes in Individuals with Type 2 Diabetes
    Cardoso, Claudia R. L.
    Leite, Nathalie C.
    Salles, Gil F.
    ENDOCRINOLOGY AND METABOLISM, 2023, 38 (03) : 305 - 314
  • [40] Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk
    Stephens, Jeffrey W.
    Brown, Karen E.
    Min, Thinzar
    DIABETES OBESITY & METABOLISM, 2020, 22 : 32 - 45
12345